RecruitingPhase 4NCT06520410

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Sponsor

Chang Gung Memorial Hospital

Enrollment

60 participants

Start Date

Mar 5, 2024

Study Type

INTERVENTIONAL

Conditions

Retinal Disease Retinal Vascular Disorder Retinopathy of Prematurity Both Eyes Persistent Fetal Vasculature Coats Disease Coats Retinopathy Familial Exudative Vitreoretinopathies Vitreous Disorder Vitreous Anomalies

Summary

This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.

Eligibility

Min Age: 0 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Pars plana vitrectomy with a 18 mm short vitrector for people with coats disease, coats retinopathy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.